Aims & Scope
Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews and research articles written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development.
 |
Frontiers in Clinical Drug Research: Anti-Infectives You can view the contents of this eBook click [here] |
"The rewards of genomics research translated into novel drug discovery using both traditional and innovative approaches will be captured in reviews of interest both to academic and applied infectious disease researches."
John Mekalanos
Harvard Medical School, USA
It is a pleasure for me to write few words on my experience of working with Bentham Science Publishers. My manuscripts published in Infectious Disorders Drug Targets found a high impact in the scientific community working on AIDS similar to high ranked journals where we used to publish our work. I am sending now our best manuscrips to this journal and I know that Infectious Disorders should becoming soon a reference in AIDS research.
Erwann Loret
Has contributed: Antiretroviral Therapy Does Not Block the Secretion of the Human Immunodeficiency Virus Tat Protein
